Need professional-grade analysis? Visit stockanalysis.com
$6.95B
N/A
N/A
N/A
Price Chart
Risk-Adjusted Performance
Maccura Biotechnology Co Ltd (300463) Price Performance
Maccura Biotechnology Co Ltd (300463) trades on SHE in CNY. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at CNY10.69, down 3.87% from the previous close.
Over the past year, 300463 has traded between a low of CNY10.69 and a high of CNY14.20. The stock has lost 20.0% over this period. It is currently 24.7% below its 52-week high.
Maccura Biotechnology Co Ltd has a market capitalization of $6.95B.
About Maccura Biotechnology Co Ltd
Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including coagulation and semi-automatic coagulation analyzers. It provides clinical chemistry products, such as glycohemoglobin and protein analyzer, biochemistry systems, and chemistry regents; blood group product solutions; and pathology solutions, such as a liquid-based cytology processing system. Maccura Biotechnology Co.Ltd was founded in 1994 and is headquartered in Chengdu, China.
Company Info
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Exchange
- SHE
- Currency
- CNY
- Country
- China
Financial Metrics
- Revenue (TTM)
- N/A
- EBITDA
- N/A
- Profit Margin
- N/A
- EPS (TTM)
- N/A
- Book Value
- N/A
Technical Indicators
- 52 Week High
- CN¥14.20
- 52 Week Low
- CN¥10.48
- 50 Day MA
- CN¥11.77
- 200 Day MA
- CN¥11.92
- Beta
- N/A
Valuation
- Trailing P/E
- N/A
- Forward P/E
- N/A
- Price/Sales
- N/A
- Price/Book
- N/A
- Enterprise Value
- $6.95B